FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride submitted by Chartwell RX, LLC as an ANDA amendment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)